Ol'GA I. Knysh

Ol'GA I. Knysh

Auto-generated profile, based on publicly available information

Ol'GA I. Knysh

Tyumen State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2023 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
AZA. V. Zhuravlev
A. V. Zhuravlev
OKO. I. Knysh
O. I. Knysh
Objective: to summarize scientific information about the basic principles of modern drug therapy for patients with chronic myeloid leukemia (CML) considering their individual characteristics.Material and methods. The basis of the study included modern scientific articles and clinical guidelines on CML diagnosis and treatment (2021), State Register of Medicines (SRM) of the Russian Federation, instructions for the use of medicines. The following methods were used: structural analysis, analytical method, content analysis, retrospective analysis, systematic approach, situational-logical and graphical methods of analysis.Results. The analysis made it possible to summarize scientific information about the basic principles of drug therapy for patients suffering from CML. It was revealed that the problem of CML therapy today is relevant, since every year there is an increase in the incidence of this nosology. Currently, the most significant is the prescription of tyrosine kinase inhibitors (TKIs), since they have pronounced effects and are well tolerated by patients. Therapy for CML in TKIs prescription consists of several lines. Imatinib is the first line therapy because it has better safety profile. There are combinations with imatinib; for example, it is used together with interferon alfa, which allows, in some cases, to increase the response to treatment. The following drugs are used in the second line: nilotinib, dasatinib, bosutinib, ponatinib. If TKI therapy is ineffective, it is possible to prescribe standard chemotherapy, interferon therapy, or bone marrow transplantation in the absence of contraindications. Studies are underway on the possibility of using and including in clinical guidelines such drugs as arsenic trioxide, decitabine, omacetaxime, inhibitors of farnesyl transferases, granulocyte-macrophage factors, antitumor vaccines. The analysis of SRM identified 27 trade names for TKIs, the share of domestic drugs was 60%. There were no Russian analogues for bosutinib and ponatinib in SRM, which are recommended for use in case of ineffective TKI therapy of previous lines.Conclusion. The study of drug provision for CML patients is an urgent task for pharmaceutical practice and for the healthcare system as a whole. Currently, the acute issues are the individual approach to the treatment of each CML patient considering concomitant diseases, and the search for new, more effective drugs that can increase the life expectancy and quality of life of patients suffering from this disease.

25 October 2021 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
VPV. V. Prokopenko
V. V. Prokopenko
TKT. I. Kabakova
T. I. Kabakova
MCM. V. Chernikov
M. V. Chernikov
AGA. B. Goryachev
A. B. Goryachev
SMS. A. Mikhailova
S. A. Mikhailova
OKO. I. Knysh
O. I. Knysh
the aim. Focused on optimizing the assortment portfolio of pharmacy organizations and improving the process of drug supply to end-consumers, the aim of the study was to analyze the regional pharmaceutical market for antihistamines.Materials and methods. In the study, the following methods were used: a content analysis of regulatory documents; a documentary observation method of the volume of antihistamines sales; a sociological survey method. The objects of the study were accounting registers in 32 pharmacy organizations for 2020, as well as the sociological survey results of 174 respondents – consumers of antihistamines.Results. The classification analysis of 38 international non-proprietary trade names of antihistamines, represented by 187 names of drugs, revealed the prevalence of the first-generation drugs (63%). On the Russian pharmaceutical market, there were also 55% of foreign production drugs. At the regional level, there are 66 types of drugs in circulation, 50% of which are second-generation ones. The cost analysis showed rather a wide rage of the pricing proposal and the economic availability of antihistamines for patients. The sociological survey revealed the fact that 46% of the consumers were ready to pay for the necessary drugs in the price range “over 100 and up to 500 rubles” (over $ 1.38 and up to $ 6.88) for one conventional package. A medical-demographic profile of the antihistamines consumer at the regional level has been made up, and guidelines for pharmaceutical specialists on managing the assortment portfolio of pharmaceutical organizations have been developed.Conclusion. As a result of the study, the following facts have been established: the seasonal peaks in the antihistamines consumption; a gradual renewal of the pharmacies assortment portfolio due to the increased consumption of the second and third generation antihistamines. The medical and demographic profile of the consumer should be taken into consideration when planning a drug provision for the patients with allergic pathologies, and it is connected with the growth in pharmacies profits due to the sale of drugs in the range from 100 to 500 rubles (from $ 1.38 to $ 6.88). The methodical recommendations have been brought to the attention of the management of regional pharmacy organizations.

3 May 2024 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
AZA. V. Zhuravlev
A. V. Zhuravlev
OKO. I. Knysh
O. I. Knysh
Objective: to conduct a STEP analysis (social, technological, economic, political) of macro-environmental factors influencing medical and drug care for patients with chronic myeloid leukemia (CML).Material and methods. The materials used were information from the official website of the Federal State Statistics Service of the Russian Federation (RF), financial reports of the Ministry of Finance of the RF, the Ministry of Industry of the RF, the Federal Customs Service of the RF, the Federal Treasury, the All-Russian Center for the Study of Public Opinion, data from the World Health Organization and the Ministry of Health of the RF, regulatory framework of the RF, data from the State Register of Medicines of the RF and information from domestic and foreign scientific publications. The object of the study was the Department of Hematology and Chemotherapy of the Regional Clinical Hospital No. 1 (Tyumen). Structural, statistical, analytical, situational-logical, mathematical, graphic methods, as well as content analysis, STEP analysis and ranking were used.Results. Providing medical and drug care to CML patients today is a vital and pressing problem in Russia and around the world. The effectiveness of pharmacotherapy directly depends on certain environmental factors, and each of them influences the functioning of a medical organization (MO) to varying degrees. Analysis of social factors made it possible to trace the dynamics and make a forecast regarding the capabilities of patients and MOs as well as the demand for drug therapy. Economic factors are based on the level of monetary income of the population and the expenditures of the RF budget on healthcare. The role of Russian export and import volumes is shown, first and foremost, the influence of these indicators on domestic prices, demand and on the macro-economic balance in general. Сreditor indebtedness changes the MO financial position and reflects the efficiency of using the monetary resources. Analysis of technological factors allowed assessing the equipment of the MO with medical facilities and drugs. The influence of such factors as the registration of new drugs for the treatment of CML patients and the digitalization program in health care was studied. Based on the analysis of political factors, the state’s interest in the development of domestic medicine and pharmacy was determined.Conclusion. The STEP analysis of external factors influencing medical and drug care for CML patients allowed identifying the most significant ones for optimizing pharmacotherapy in this category of patients, which is relevant for medical practice and the pharmaceutical industry.

1 November 2023 in Siberian Journal of Life Sciences and Agriculture
Verified
Journal Article
Open access
PDF file
ZMZhanna V. Mironenkova
Zhanna V. Mironenkova
SUSergey Z. Umarov
Sergey Z. Umarov
OKOlga I. Knysh
Olga I. Knysh
LGLyaysan M. Gabdulkhakova
Lyaysan M. Gabdulkhakova
MMMokhamad A.E.Kh. El' Mussavi
Mokhamad A.E.Kh. El' Mussavi
The changing trade procedures within the healthcare system aim to improve the procurement mechanisms for medical products (MP), means of supplier identification, ways to reduce contract prices, and informational foundation for contracting. Research on the efficiency of MP procurement systems in the federal subjects of the Russian Federation and legislative acts applied to them is especially relevant today. This work aims to compare structural differences in contract-regulated MP procurement systems in the Republic of Bashkortostan (RB). The official website www.zakupki.gov.ru provides data on volumes and structure of MP supply in medical and pharmaceutical organizations of the RB. This paper contains the indexes of supplier and consumer rotation in the RB trade in 2013 and 2017 and a comparative analysis of tenders according to the form of order placement. The authors calculated the efficiency gains of signed contracts and conducted a comparative analysis of the examined tenders in the MP procurement system according to federal legislation (federal laws). The work undertaken allowed the authors to determine development tendencies in the competition among MP suppliers, identify the structural specificity of the MP tenders, and demonstrate their efficiency. The authors present conclusions drawn based on the comparative analysis and provide recommendations on the improvement of MP procurement in the RB. They identify the high potential of the republic to implement digital public auctions as a form of an MP procurement mechanism in accordance with Federal Law No. 223-FZ. Изменения в процедурах проведения торгов для нужд здравоохранения направлены на совершенствование системы закупок лекарственных препаратов (ЛП) в области способов определения поставщиков, снижения цен контрактов, информационного обеспечения контрактной системы. Особую актуальность имеют исследования эффективности системы закупок ЛП на уровне субъектов РФ с учетом применяемых нормативно-правовых актов. Цель работы: проведение сравнительного анализа по структурным особенностям закупок ЛП в условиях контрактной системы на уровне субъекта РФ – Республики Башкортостан (РБ). Методы исследования: Источником информации об объемах и структуре закупок ЛП медицинскими и фармацевтическими организациями в РБ являлся официальный сайт РФ www.zakupki.gov.ru. В статье приведены результаты определения индексов обновления поставщиков и заказчиков, участвовавших в торгах в 2013 и 2017 г.г.; сравнительного анализа торгов по форме размещения. Рассчитана экономия финансовых средств по результатам заключения контрактов, проведен её сравнительный анализ. Результаты и обсуждение: Сравнительный анализ проводимых торгов в электронной форме в соответствии с федеральными законами (ФЗ) в системе закупок ЛП позволил выявить тенденции в развитии конкуренции среди поставщиков ЛП. Установлены структурные особенности торгов, показана их эффективность. По результатам сравнительного анализа представлены выводы и приведены рекомендации, направленные на совершенствование лекарственного обеспечения в РБ. Выявлено, что в Республике Башкортостан имеется высокий уровень потенциала для проведения закупок ЛП в виде открытого аукциона в электронной форме в соответствии с ФЗ-223.

2 June 2022 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
VBV. V. Byshenko
V. V. Byshenko
ОKО. I. Knysh
О. I. Knysh
LZL. N. Zadirachenko
L. N. Zadirachenko
АEА. О. Egorova
А. О. Egorova
YRYu. S. Rodina
Yu. S. Rodina
Objective: to assess the current state of the veterinary medical product market in the Tyumen Region.Material and methods. The objects of the study included data from the State Register of Medicinal Products for Veterinary Use for 2019–2022; veterinary pharmacy organizations and veterinary clinics in the Tyumen Region (33); price lists of veterinary pharmaceutical organizations; questionnaires of veterinary specialists (69) and consumers of medicinal products for veterinary use (93).Results. An analysis of the Register of Medicinal Products for Veterinary Use registered in the Russian Federation revealed a positive trend in the registration of new positions: with 2190 registered drugs about 300 more positions are registered annually. It was determined that the ratio of veterinary drugs of various pharmacotherapeutic groups is critically uneven (31.05% – antibacterial agents; 28% – immunobiological drugs; 0.46% – cardiovascular drugs; 0.14% – antitumor drugs). The study of the wholesale segment of the veterinary drugs market on the territory of the Tyumen Region showed that the range of wholesale trade organizations in veterinary drugs mainly consists of products for animals (at the largest one veterinary drugs account for only 16%). As a result, low indicators of the assortment are observed (breadth and completeness coefficients for pharmacotherapeutic groups), and there are problems with the availability of veterinary drugs. The analysis of the assortment of veterinary pharmaceutical organizations and clinics (retail segment of the market) revealed low breadth coefficients for medicinal products for veterinary use (median 0.09). A sociological survey showed a low level of awareness of all veterinary drugs consumer groups about the scope of their circulation.Conclusion. The study of the current state of the veterinary medicinal product market in the Tyumen Region identified the problems of their availability both in the wholesale and retail segments, which need to be addressed with the help of state regulation (including the introduction of a minimum range of drugs for veterinary use) and normalization of the assortment policy at the level of veterinary pharmacies and clinics. Because of the lack of registration for some drugs necessary for the treatment of animals, veterinarians are forced to put into practice drugs for medical use, deliberately violating the law. Given the experience of many foreign countries, we consider it expedient to allow the use (in special cases) of medical drugs in veterinary medicine. This will solve the problem of pharmacotherapy availability and allow veterinarians to provide better care to animals.

21 December 2020 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
MMM.A.E. El Moussawi
M.A.E. El Moussawi
ZMZh. V. Mironenkova
Zh. V. Mironenkova
SUS. Z. Umarov
S. Z. Umarov
OKO. I. Knysh
O. I. Knysh
ONOksana Nemyatykh
Oksana Nemyatykh
The objective of the research was to conduct a comparative analysis of the development of Lebanon based on a number of demographic, economic and social indicators characterizing the health care of Lebanon, and to determine the prospects for the cooperation with the Russian Federation (RF) in the pharmacy field.Materials and methods. The studies were conducted from 2009 to 2016. The objects were the statistical data accumulated on the basis of the data from national institutions and international organizations. These data were published annually in the reports of the Department of Economic and Social Affairs, the United Nations Population Division for 11 countries in the Middle East: Bahrain, Jordan, Yemen, Kuwait, Lebanon, United Arab Emirates, Oman, Saudi Arabia (Asian countries); Egypt, Sudan, Tunisia (North African countries). The research methods were: a comparative analysis, analytical grouping of data, ranking.Results. A comparative analysis of demographic, economic and social indicators revealed that low mortality rates and high life expectancy in Lebanon were achieved both due to a satisfactory level of health care financing (Rank 5) and due to the adoption of adequate decisions in organizing and managing the Lebanese health care system. The positive trends that were inherent in the Lebanese health care system in previous decades continued to operate within the framework of earlier inertia, while migration flows intensified. However, there has been a slowdown in the decline in infant mortality in the dynamics of growth rates, which is a signal of the emergence of negative processes in the social sphere of the country.Conclusion. The current situation in the Lebanese health care system, associated with limited financial resources, poses new challenges in the search for managerial decisions in the field of organizational management. The import of drugs from the Russian Federation will provide a significant reduction in the financial costs of providing the population of Lebanon and migrants with medicines which will increase the monetary costs of providing medical care.